Effects of Sensori-motor Integration Balance Training on Balance Disturbances in Patients With Multiple Sclerosis

CompletedEarly phase 1Relapsing MSNCT01040117

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Sensory-motor Integration Training

Compared with

  • Conventional neurorehabilitation treatment

What it measured

Main measures

  • Clinical assessment procedures: - Berg Balance Scale (BBS) - Activities-specific Balance Confidence Scale (ABC) Instrumental assessment procedures: - Stabilometric assessment

    At recruitment, after treatment (5 weeks) and in the follow-up (1 month)

    Walking and mobility

Other measures (1)

  • Clinical evaluation - Walking evaluation - Multiple Sclerosis Quality Of Life-54 (MSQOL-54) - Fatigue Severity Scale (FSS) - Postural Transfers

    At recruitment, after treatment (5 weeks) and in the follow-up (1 month)

    FatigueWalking and mobilityQuality of life (reported by participants)

Who could take part

Relapsing MS · 18 to 65

Show the full criteria

Inclusion criteria

* Age \< 65 years * Expanded Disability Status Scale (EDSS) 2.0 > score \< 6.0 (24) * Mini Mental State Evaluation (MMSE) score ≥ 24 * Absence of cognitive impairment * Absence of heart problems * Self-reported sensation of postural instability * Ability to maintain standing position without aids for at least 1 minute * Ability to walk independently for at least 15 metres

Exclusion criteria

* Disease recurrence that worsens significantly during the 3 months prior to recruitment * Pharmacological therapy not well defined * Presence of vestibular disorders and/or paroxysmal vertigo * Performance of any type of rehabilitation treatment in the month prior to recruitment * Presence of other concurrent neurological or orthopaedic diseases involving the lower limbs and/or interfering with standing position and/or walking.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Balance impairment is a common and very disabling disturbance in people with Multiple Sclerosis. The efficacy of pharmacotherapy in treating balance impairment in MS is poorly documented in literature. Although literature dealing with the rehabilitation of balance impairment in MS is very scant, the preliminary data reports show very promising results. The present project could have a positive impact on balance and gait ability, disability, fear of falling, risk of falls and quality of life of patients with Multiple Sclerosis.

Papers

Loading reviews and guidelines…

History

    1. Started

      Dec 2009

    2. Main results due

      Oct 2011

    3. Finished

      Jan 2012

    Assembled by software from public sources.